Potassium bicarbonate/potassium citrate - AdvicenneAlternative Names: ADV 7103; Potassium citrate monohydrated/potassium hydrogen carbonate - Advicenne; Potassium citrate/potassium bicarbonate - Advicenne; Potassium hydrogen carbonate/potassium citrate monohydrated - Advicenne
Latest Information Update: 27 Oct 2015
At a glance
- Originator Advicenne
- Class Alkalinising agents; Electrolytes; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Kidney disorders
Most Recent Events
- 05 Oct 2015 Phase-II/III clinical trials in Kidney disorders in France (PO)